From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Increased Mortality with Calcium Channel Blockers?

In what is the largest study by far to explore the possibility of adverse effects associated with calcium channel blockers, researchers from the Nurses' Health Study examined outcomes in 14,167 women with hypertension treated with calcium channel blockers, thiazide diuretics, ß -blockers, or ACE inhibitors in 1988.

By 1994, 385 women had suffered a first cardiovascular event. After adjustment for cardiovascular history and other risk factors, calcium channel blockers were associated with a 64 percent increase in risk for myocardial infarction, relative to women on diuretics alone. Among women with no history of cardiovascular disease in 1988, calcium blockers were associated with a 65 percent increase in risk for myocardial infarction. Risks were higher among women who used calcium channel blockers in combination with other antihypertensive agents. Multivariate analysis also found increased risk for total mortality among calcium channel blocker users.

Comment: This prospective study must be interpreted with caution because it does not reflect the predominant use of long-acting calcium blockers today. However, it is not reassuring for those who hope calcium channel blockers might improve the prognosis for women with hypertension.

— TH Lee

Published in Journal Watch General Medicine May 1, 1998

Citation(s):

Michels KB et al. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: The Nurses' Health Study. Circulation 1998 Apr 28 97 1540-1548.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1998. Massachusetts Medical Society. All rights reserved.